Prognostic markers for CAR-T cell therapy in patients with relapsed/refractory multiple myeloma

被引：0

作者：

Liu, Yang ^{[1
]}

Yan, Zhiling ^{[2
]}

Wu, Qingyun ^{[2
]}

Chen, Chong ^{[2
]}

Cao, Jiang ^{[2
]}

Li, Zhenyu ^{[2
]}

Xu, Kailin ^{[2
]}

机构：

[1] Xuzhou Med Univ, Dept Hematol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China

[2] Xuzhou Med Univ, Blood Dis Inst, Xuzhou, Jiangsu, Peoples R China

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-029

引用

页码：S49 / S49

页数：1

共 50 条

[21] Fragile Warriors: Navigating the Delicate Dance of Frailty and CAR-T cell Therapy for Relapsed/Refractory Multiple Myeloma
Friend, Reed
Atrash, Shebli
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 253 - 254
[22] Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
Jin, Chunxiang
Chen, Rongrong
Fu, Shan
Zhang, Mingming
Teng, Yuanyin
Yang, Tingting
Song, Fengmei
Feng, Jingjing
Hong, Ruimin
Cui, Jiazhen
Huang, Simao
Xu, Huijun
Zhang, Yanlei
Wei, Guoqing
Cai, Zhen
Kwong, Yok-Lam
Chan, Thomas Sau Yan
Chang, Alex H.
Huang, He
Hu, Yongxian
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
[23] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
Mei, Heng
Li, Chenggong
Jiang, Huiwen
Zhao, Xinying
Huang, Zhiping
Jin, Dan
Guo, Tao
Kou, Haiming
Liu, Lin
Tang, Lu
Yin, Ping
Wang, Zhihui
Ai, Lisha
Ke, Sha
Xia, Yimeng
Deng, Jun
Chen, Lei
Cai, Li
Sun, Chunyan
Xia, Linghui
Hua, Gaoquan
Hu, Yu
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[24] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
Heng Mei
Chenggong Li
Huiwen Jiang
Xinying Zhao
Zhiping Huang
Dan Jin
Tao Guo
Haiming Kou
Lin Liu
Lu Tang
Ping Yin
Zhihui Wang
Lisha Ai
Sha Ke
Yimeng Xia
Jun Deng
Lei Chen
Li Cai
Chunyan Sun
Linghui Xia
Gaoquan Hua
Yu Hu
Journal of Hematology & Oncology, 14
[25] Failure of CAR-T cell therapy in relapsed and refractory large cell lymphoma and multiple myeloma: An urgent unmet need
Martin, Yasmine St.
Franz, Joseph K.
Agha, Mounzer E.
Lazarus, Hillard M.
BLOOD REVIEWS, 2023, 60
[26] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
Al Hadidi, Samer
Szabo, Aniko
Esselmann, Jean
Hammons, Lindsay
Hussain, Munawwar
Ogunsesan, Yetunde
Thalambedu, Nishanth
Khan, Fatima
Sethi, Jaskirat
Janardan, Abhishek
Radhakrishnan, Sabarinath Venniyil
Thanendrarajan, Sharmilan
Schinke, Carolina
Dhakal, Binod
Janz, Siegfried
Chhabra, Saurabh
D'Souza, Anita
Zangari, Maurizio
van Rhee, Frits
Mohan, Meera
BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
[27] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
Samer Al Hadidi
Aniko Szabo
Jean Esselmann
Lindsay Hammons
Munawwar Hussain
Yetunde Ogunsesan
Nishanth Thalambedu
Fatima Khan
Jaskirat Sethi
Abhishek Janardan
Sabarinath Venniyil Radhakrishnan
Sharmilan Thanendrarajan
Carolina Schinke
Binod Dhakal
Siegfried Janz
Saurabh Chhabra
Anita D’Souza
Maurizio Zangari
Frits van Rhee
Meera Mohan
Bone Marrow Transplantation, 2023, 58 : 443 - 445
[28] CAR-T cell therapy for relapsed or refractory multiple myeloma in 2024-clinically available treatment options in Austria
Strassl, Irene
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (04) : 242 - 246
[29] A suggestion to improve the results of "Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma"
Arash, Majid
CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
[30] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
Feng, Deming
Sun, Jian
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)

← 1 2 3 4 5 →